GI Accelerate Memphis LLCFDA
- FEI
- 3006500433
- Record date
- Establishment
- Manufacturer
- Location
- Tennessee, United States
Every published Form FDA 483 issued in October 2025, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
8
Published 483s in October 2025
8
Distinct firms
| Company | FEI | Establishment type | Location | FDA date | Source |
|---|---|---|---|---|---|
| GI Accelerate Memphis LLC | 3006500433 | Manufacturer | Tennessee, United States | FDA | |
| ICON plc | 3038011239 | Bioanalytical Lab | Netherlands | FDA | |
| Lonza AG | 3002930340 | Drug Substance Manufacturer | Switzerland | FDA | |
| Alps Pharmaceutical Industrial Co., Ltd. | 3002806352 | Active Pharmaceutical Ingredient Manufacturer | Japan | FDA | |
| Inotiv Inc | 1000140135 | Biopharmaceutics Analytical Facility & Nonclinical Laboratory | United States | FDA | |
| Lonza Guangzhou Pharmaceutical Ltd. | 3006532186 | Active Pharmaceutical Ingredient Manufacturer | China | FDA | |
| UBI Pharma, Inc. | 3004713402 | Drug Manufacturer | Taiwan | FDA | |
| SCA Pharmaceuticals, Inc. | 3010683157 | Outsourcing Facility | Arkansas, United States | FDA |